Some *ortho*-phthalates, including di(2-ethylhexyl) phthalate (DEHP) and di-*n*-butyl phthalate (DBP), have been identified as reproductive and developmental toxicants in laboratory animals ([@r16]; [@r21]). Similar effects have not been reported in animals exposed to diethyl phthalate (DEP); however, limited human studies have suggested a possible association between DEP exposure and male reproductive health outcomes ([@r36]). Studies have shown widespread population exposure to background levels of phthalates ([@r33]). Of concern, particularly high exposure levels may result from orally ingested medicinal products containing phthalates as inactive ingredients. For example, increased urinary concentrations of phthalate metabolites were first reported for an individual taking a mesalamine product (Asacol; Warner Chilcott Pharmaceuticals Inc., Mason, OH) ([@r17]) and later confirmed for individuals taking mesalamine and other drug products ([@r20]). High urinary concentrations of phthalate metabolites have also been identified in patients with cystic fibrosis who used pancreatic enzyme products ([@r22]). This has led to increased interest in identifying additional drug products that contain phthalates as inactive ingredients.

Inactive ingredients (excipients) are defined as "any component other than the active ingredient in a drug product" (FDA 2011). These various compounds may be used in drug formulations for a number of functions related to the preparation and stability of the physical dosage form or the delivery of active ingredients ([@r31]). Excipients used in specialized drug product formulations may permit *a*) localized availability of active medications in various sections of the gastrointestinal (GI) tract, *b*) controlled release of a medication over time, or *c*) through the skin. Phthalates, in combination with various polymers, may be used as plasticizers and film coating agents in orally ingested solid pharmaceutical dosage forms and in numerous types of modified-release drug delivery systems such as enteric-coated and delayed-release tablets, pelletized delayed-release capsules, enteric-coated capsules, and controlled-release transdermal films ([@r2]).

Several different phthalates are currently used as excipients in approved pharmaceutical formulations: diethyl phthalate (DEP), dibutyl phthalate (DBP), dimethyl phthalate (DMP), dioctylphthalate (DOP), hypromellose phthalate (HMP), cellulose acetate phthalate (CAP), polyvinyl acetate phthalate (PVAP), and polyethylene terphthalate (PET) \[Food and Drug Administration (FDA) 2010b\]. These compounds are not themselves technically "approved" for general use as excipients; rather, they are permitted to be included in their corresponding approved drug products, with maximum levels designated for each type of dosage form and route of administration ([@r29]; [@r35]). The maximum amount of DBP used in specific FDA-approved drug products ranges from 1.70 mg for a delayed-action, enteric-coated tablet formulation to 11.18 mg for an extended-release capsule product. DEP has been approved at amounts ranging from 0.5 mg for an uncoated, chewable tablet to 16.8 mg for a delayed-action, enteric-coated capsule (FDA 2010b).

Nonprescription pharmaceutical (over-the-counter; OTC) and dietary supplement products may contain excipients found in approved prescription (RX) products; however, their composition is not always reviewed prior to marketing. OTC drug products marketed under monograph guidelines do not require premarket review of their ingredients, but contents are reviewed for products approved under new drug applications (NDAs) and abbreviated NDAs (ANDAs) (FDA 2010a). Dietary supplements are regulated as food products under the Dietary Supplement Health and Education Act of 1994 ([@r10]), and their formulations do not require approval prior to marketing unless they contain a new dietary ingredient (FDA 2009).

Manufacturers are required to disclose a listing of inactive ingredients in drug product labeling, except when they are used in patented delivery mechanisms where the composition is considered to be a confidential trade secret (U.S. Pharmacopeial Convention 2009). Although the FDA might have information on the type and amount of phthalates used in specific approved drug products, they cannot make the information public because of its proprietary nature.

In this study we sought to identify and describe the scope of medicinal pharmaceutical products and dietary supplements marketed in the United States and Canada since 1995 that could be confirmed to contain phthalates as excipients based on available product information supplied by regulators, manufacturers, labelers, distributors, and marketers of these products.

Methods
=======

A search of the published literature on the use of phthalates in orally ingested medications suggested that phthalates are frequently included as inactive ingredients in modified-release drug formulations (i.e., controlled-release, delayed-release, or targeted-release systems), as well as in formulations for film coatings. Drug products using these formulations rely on the integrity of their coating systems for proper delivery of their active ingredients and therefore should not be crushed or chewed. Lists of drug products that are not recommended to be crushed or chewed have been published for reference by health care professionals to ensure their proper administration ([@r23]; Thomson PDR 2006). We used these lists, which included approximately 450 product names, to complete an initial screen of drug product labeling for the inclusion of phthalates as excipients.

All inactive ingredients for RX medications on the "do not crush list" were first reviewed using a combination of print and electronic resources including the *Physicians' Desk Reference* (Thomson Healthcare 1995--2010a), FDA Approved Drug Products database (Drugs\@FDA; FDA 2011b), DailyMed \[National Library of Medicine (NLM) 2011a\], and LabelDataPlus ([@r30]). Canadian products with comparable active ingredients and formulations were researched by using any available monographs from the Health Canada Drug Product Database ([@r18]) and the *CPS: Compendium of Pharmaceuticals and Specialties* (Canadian Pharmaceutical Association 1995--2006). Names of brand and generic drug products marketed since 1995 appearing on the lists were searched within each available electronic or print reference, and all potential modified-release formulations were selected from the results. Once a label was located, we searched the document for all inactive ingredients. If multiple labels were available within a database, we investigated all potential inactive ingredient formulation changes by reviewing the older labels. If an older formulation of the product contained phthalates but the newer formulations did not, we searched all available labels by revision date to determine when the formulation changed. If none of the available compendia provided sufficient label information for a product, we searched the manufacturer or distributor website. If no label was found, we contacted the manufacturer and requested a copy of the package insert.

We performed further Internet searches using terms containing "phthalate" and "medication," or suspected medication names and drug classes (e.g., bisacodyl, enzyme), to locate additional products and product categories. Patents for proprietary drug delivery systems were reviewed for the use of phthalate plasticizers in specific drug products or groups of products.

Several OTC medications and dietary supplement products were listed on the "do not crush" list; however, most available references including the *Physicians' Desk Reference for Nonprescription Drugs, Dietary Supplements, and Herbs* (Thomson Healthcare 1995--2010b), Drugs\@FDA, LabelDataPlus, DailyMed, and Dietary Supplements Labels Database (NLM 2011b) either did not include these products or did not provide complete, searchable label information on their inactive ingredients. For these products, we obtained detailed information on inactive ingredients from manufacturer and distributor web sites, or if possible, directly from product package labeling retrieved from store shelves. Canadian dietary supplement products were searched using the Health Canada Licensed Natural Health Products Database (LNHPD; [@r19]), which currently contains information on approximately 16,000 licensed dietary supplements available in solid oral dosage forms.

Results
=======

*Use in prescription drugs.* Various phthalates were identified in RX medications available in the United States and Canada across a wide variety of therapeutic classes, including analgesic, antibiotic, GI, cardiovascular, and antiepileptic drug products. As expected, we found that phthalates were most commonly used in modified-release RX drug formulations that provided timed-release and targeted-release of active ingredients. Of the RX products that were identified, 75 contained the phthalate polymers HMP, CAP, and PVAP (data not shown), and 50 contained the *ortho*-phthalates DEP and/or DBP (6 contained DBP, and 1 contained both DEP and DBP) ([Table 1](#t1){ref-type="table"}).

###### 

Prescription drug products marketed in the United States and Canada listing *ortho*-phthalates as inactive ingredients in product labeling, 1995--2011.

  Generic name                                                                                                                                                      Trade name*a*   Labeler/manufacturer                                 Phthalate   Drug class                                                                   
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------- ---------------------------------------------------- ----------- ------------------------------------------------------ -- --------------- -- -----------------------------
  Acebutolol                                                                                                                                                                        Rhotral 400 mg tablets (Canada)(discontinued 2006)               Rhodiapharm (Canada)                                      DEP                Cardiovascular/beta blocker
  Carbamazepine                                                                                                                                                                     Carbamazepine 200 mg tablet                                      Teva Pharmaceuticals USA Inc.                             DEP                Antiepileptic
                                                                                                                                                                                    Taro-Carbamazepine CR (Canada)                                   Taro Pharmaceuticals Inc. (Canada)                        DEP                
  Cyclobenzaprine                                                                                                                                                                   Amrix                                                            Cephalon Inc.                                             DEP                Muscle relaxant
                                                                                                                                                                                    Cyclobenzaprine HCl Extended Release Capsules                    CIMA Labs Inc./Eurand                                     DEP                
  Didanosine                                                                                                                                                                        Didanosine, Enteric Coated                                       Aurobindo Pharma Ltd.                                     DEP                Antiretroviral
                                                                                                                                                                                    Didanosine, Enteric Coated                                       Mylan Pharmaceuticals Inc.                                DEP                
                                                                                                                                                                                    Videx EC (United States and Canada)                              Bristol Myers Squibb Co./Bristol Myers Squibb Canada      DEP                
  Diltiazem                                                                                                                                                                         Cardizem CD 360 mg Capsule                                       BTA Pharmaceuticals Inc.                                  DEP                Cardiovascular/CCB
                                                                                                                                                                                    Dilt-CD                                                          Apotex Corp.                                              DBP                
                                                                                                                                                                                    Diltiazem Extended Release (Twice-A-day)                         Mylan Pharmaceuticals Inc.                                DEP                
  Divalproex                                                                                                                                                                        Divalproex sodium tablet, delayed release                        Aurobindo Pharma Limited                                  DEP                Antiepileptic
                                                                                                                                                                                    Divalproex sodium tablet, delayed release                        Greenstone LLC/Aurobindo Pharma                           DEP                
  Erythromycin                                                                                                                                                                      ERYC (Canada)                                                    Pfizer Canada Inc.                                        CAP, DEP           Antibiotic
  Ethopropazine                                                                                                                                                                     Parsitan (Canada)                                                Rhone-Poulenc Rorer/Erfa Canada Inc.                      DEP                Antiparkinsons
  Galantamine                                                                                                                                                                       Razadyne ER                                                      Ortho-McNeil Neurologics                                  DEP                Antiparkinsons
                                                                                                                                                                                    Galantamine HBr Extended Release Capsules                        Global Pharmaceuticals/Impax Laboratories Inc.            DEP                
                                                                                                                                                                                    Reminyl ER (Canada)                                              Janssen-Ortho Inc.                                        DEP                
  Isosorbide                                                                                                                                                                        Isosorbide Mononitrate, tablet extended release                  Torrent Pharmaceuticals Ltd.                              DEP                Cardiovascular/vasodilator
  Ketoprofen                                                                                                                                                                        Nu-Ketoprofen E (Canada)                                         Nu-Pharm (Canada)                                         CAP, DEP           NSAID
                                                                                                                                                                                    Orudis SR (Canada) (discontinued 2005)                           Aventis Pharma (Canada)                                   CAP, DEP           
  Mesalamine                                                                                                                                                                        Asacol (United States and Canada)                                Warner Chilcott US LLC/Warner Chilcott Canada Co.         DBP                GI/anti-inflammatory
                                                                                                                                                                                    Asacol HD                                                        Warner Chilcott US LLC.                                   DBP                
                                                                                                                                                                                    Asacol 800 (Canada)                                              Warner Chilcott Canada Co.                                DBP                
                                                                                                                                                                                    Salofalk 500 mg Enteric Coated (Canada)                          Axacan Pharma Inc.                                        DEP                
  Morphine sulfate                                                                                                                                                                  Kadian                                                           Actavis Kadian; Alpharma Branded Products                 DEP                Analgesic
                                                                                                                                                                                    Morphine Sulfate Extended Release Capsules                       Actavis Elizabeth LLC                                     DEP                
  Morphine sulfate/naltrexone                                                                                                                                                       Embeda                                                           King Pharmaceuticals/Actavis                              DEP                Analgesic
  Pancrelipase                                                                                                                                                                      Cotazym ECS (OTC in Canada)                                      Organon Canada Ltd./Schering-Plough Canada Inc.           CAP, DEP           GI/enzyme
                                                                                                                                                                                    Creon Minimicrospheres                                           Solvay Pharmaceuticals Inc.                               DBP, HMP           
                                                                                                                                                                                    Lipram                                                           Eurand America                                            DEP, HMP           
                                                                                                                                                                                    Pancrease                                                        McNeil                                                    CAP, DEP           
                                                                                                                                                                                    Pancrecarb                                                       Digestive Care Inc.                                       CAP, DEP           
  Potassium chloride                                                                                                                                                                Potassium Chloride Extended Release Tablets, USP                 American Health Packaging/Watson/Eurand                   DEP                Potassium supplement
                                                                                                                                                                                    Riva-K 20 SR (Canada)                                            Laboratories Riva Inc. (Canada)                           DEP                
  Prochlorperazine                                                                                                                                                                  Stemetil tablets (Canada) (discontinued 2005)                    Rhone-Poulenc Rorer/Aventis Pharma                        DEP                Antiemetic
  Propranolol                                                                                                                                                                       InnoPran XL                                                      GlaxoSmithKline                                           DEP, HMP           Cardiovascular/beta blocker
  Ranitidine                                                                                                                                                                        Ranitidine Tablets, USP 150 mg                                   Wockhardt USA, LLC                                        DEP                GI/antiulcer-H2 Blocker
                                                                                                                                                                                    Ranitidine Tablets, USP 300 mg                                   Wockhardt USA, LLC                                        DEP                
  Sulfasalazine                                                                                                                                                                     Sulfasalazine Delayed Release Tablets, USP                       Vintage Pharmaceuticals                                   CAP, DEP           GI/anti-inflammatory
                                                                                                                                                                                    Sulfazine EC                                                     Qualitest/Vintage Pharmaceuticals-Charlotte               CAP, DEP           
  Theophylline                                                                                                                                                                      Theo-Dur Extended Release Tablets                                Key Pharmaceuticals                                       CAP, DEP           Respiratory/bronchodilator
                                                                                                                                                                                    Uni-Dur Extended Release Tablets                                 Key Pharmaceuticals                                       CAP, DEP           
  Thioproperazine mesylate                                                                                                                                                          Majeptil (Canada)                                                Rhone-Poulenc Rorer/Erfa Canada Inc.                      DEP                Antipsychotic
  Trimipramine                                                                                                                                                                      Rhotrimine Tablets (Canada)(discontinued 2006)                   Rhodiapharm (Canada)                                      DEP                Antidepressant
  Typhoid vaccine, oral                                                                                                                                                             Vivotif (Canada)                                                 Crucell Switzerland Ltd.                                  DBP, DEP, HMP      Vaccine
  Valproic acid                                                                                                                                                                     ratio-Valproic 500 mg Capsules (Canada)                          ratiopharm (Canada)                                       CAP, DEP           Antiepileptic
                                                                                                                                                                                    phl-Valproic Acid 500 mg Capsules (Canada)                       Pharmel Inc.                                              CAP, DEP           
  Verapamil                                                                                                                                                                         Verapamil HCL Extended Release Capsules                          Mylan Pharmaceuticals Inc.                                DEP                Cardiovascular/CCB
                                                                                                                                                                                    Verapamil HCL PM Extended Release Capsules                       Mylan Pharmaceuticals Inc.                                DEP                
  Abbreviations: CCB, calcium channel blocker; NSAID, nonsteroidal anti-inflammatory drug. **a**Applies to all strengths and dosage forms unless otherwise noted.                                                                                                                                                                 

*Use in OTC drugs and dietary supplements.* Enteric coatings, film coatings, and specialized capsule formulations utilizing phthalates were noted for a number of different product categories and purposes in OTC drugs and supplements. These functions included prevention of premature degradation of substances such as enzymes, acid reducers, and probiotics by stomach acid; reduce stomach upset from iron and laxatives; minimize the aftertaste from fish oil and garlic; and produce soft gelatin capsules (i.e., "softgels") that may be easier to swallow or contain solubilized drugs and oils (e.g., ibuprofen, fish oil).

Thirty-eight of the OTC drug products ([Table 2](#t2){ref-type="table"}) and 24 of the dietary supplement products ([Table 3](#t3){ref-type="table"}) located listed DEP, and 93 included phthalate polymers (data not shown). Although there were only 3 ANDAs for OTC ranitidine detailing the use of DEP, they were linked to label information for an additional 31 private label antacid products. Only 1 OTC drug available both in the United States and Canada \[Dulcolax Laxative Tablets (Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA; and Boehringer Ingelheim (Canada) Ltd./Ltée, Burlington, Ontario, Canada\] and 2 older formulations of dietary supplement products listed DBP \[Venastat Leg Vein Health (Boehringer Ingelheim Pharmaceuticals) and Wobenzym N (Mucos Pharma, Průhonice, Czech Republic)\].

###### 

Nonprescription drugs products marketed in the United States and Canada listing *ortho*-phthalates as inactive ingredients in product labeling, 1995--2011.

  Generic name                                                                                                                                                                                                                                                                                                                                  Trade name*a*   Labeler/manufacturer                         Phthalate   Drug class                                                                     
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------- -------------------------------------------- ----------- ------------------------------------------------------- -- ---------------- -- -------------------------
  Brompheniramine                                                                                                                                                                                                                                                                                                                                               Dimetane Allergy Extentabs                               Whitehall-Robins                                           CAP, DEP            Antihistamine
  Aspirin-delayed release                                                                                                                                                                                                                                                                                                                                       Entrophen ECT 975 mg (Canada)                            Pendopharm, Division of/de Pharmascience Inc (Canada)      CAP, DEP            Analgesic/antipyretic
                                                                                                                                                                                                                                                                                                                                                                Enteric Coated A.S.A. (Canada)                           Pendopharm, Pharmascience (Canada)                         CAP, DEP, PVAP      
  Bisacodyl                                                                                                                                                                                                                                                                                                                                                     Dulcolax Bisacodyl Laxative Tablets                      Boehringer Ingelheim                                       DBP                 GI/laxative
                                                                                                                                                                                                                                                                                                                                                                Dulcolax ECT 5 mg (Canada)                               Boehringer Ingelheim Canada Ltd.                           DBP                 
  Omeprazole                                                                                                                                                                                                                                                                                                                                                    Omesec Delayed Release Capsules                          Corporation Infarmasa                                      DEP, HMP            GI/antiulcer-PPI
  Ranitidine                                                                                                                                                                                                                                                                                                                                                    Ranitidine 75 mg (Wockhardt)*b*                          Wockhardt USA LLC                                          DEP                 GI/antiulcer-H2 blocker
                                                                                                                                                                                                                                                                                                                                                                Ranitidine 150 mg (Wockhardt)*c*                         Wockhardt USA LLC                                          DEP                 
                                                                                                                                                                                                                                                                                                                                                                Ranitidine 75 mg (Wockhardt)*d*                          Wockhardt USA LLC                                          DEP                 
                                                                                                                                                                                                                                                                                                                                                                Berkley & Jensen Acid Reducer 150 mg*c*                  BJWC                                                       DEP                 
                                                                                                                                                                                                                                                                                                                                                                Care One Acid Reducer 75 mg*b*                           American Sales Company                                     DEP                 
                                                                                                                                                                                                                                                                                                                                                                CVS Maximum Strength Acid Reducer*c*                     CVS Pharmacy                                               DEP                 
                                                                                                                                                                                                                                                                                                                                                                DG Health Acid Reducer 75 mg*b*                          Dolgencorp Inc.                                            DEP                 
                                                                                                                                                                                                                                                                                                                                                                DG Health Acid Reducer 150 mg*c*                         Dolgencorp Inc.                                            DEP                 
                                                                                                                                                                                                                                                                                                                                                                Equaline Acid Reducer Ranitidine 150 mg*c*               Supervalu Inc.                                             DEP                 
                                                                                                                                                                                                                                                                                                                                                                Equaline Heartburn Relief 75 mg*b*                       Supervalu Inc.                                             DEP                 
                                                                                                                                                                                                                                                                                                                                                                Formucare Ranitidine 75*b*                               Access Business Group International LLC                    DEP                 
                                                                                                                                                                                                                                                                                                                                                                Good Neighbor Acid Reducer 150 mg*c*                     Amerisource Bergen                                         DEP                 
                                                                                                                                                                                                                                                                                                                                                                Good Neighbor Acid Reducer 75 mg*b*                      Amerisource Bergen                                         DEP                 
                                                                                                                                                                                                                                                                                                                                                                Goodsense Acid Reducer 150 mg*c*                         L Perrigo Company                                          DEP                 
                                                                                                                                                                                                                                                                                                                                                                Goodsense Acid Reducer 75 mg*b*                          L Perrigo Company                                          DEP                 
                                                                                                                                                                                                                                                                                                                                                                Kirkland Signature Acid Reducer*c*                       Costco Wholesale Corporation/Perrigo                       DEP                 
                                                                                                                                                                                                                                                                                                                                                                Kroger Heartburn Relief 75 mg*b*                         Kroger Company                                             DEP                 
                                                                                                                                                                                                                                                                                                                                                                Leader Acid Control 75 mg*b*                             Cardinal Health                                            DEP                 
                                                                                                                                                                                                                                                                                                                                                                Leader Acid Control 150 mg*c*                            Cardinal Health                                            DEP                 
                                                                                                                                                                                                                                                                                                                                                                Major Ranitidine 150 Maximum Strength*c*                 Major Pharmaceuticals                                      DEP                 
                                                                                                                                                                                                                                                                                                                                                                Major Ranitidine 75*b*                                   Major Pharmaceuticals                                      DEP                 
                                                                                                                                                                                                                                                                                                                                                                Medicine Shoppe Acid Reducer 75 mg*b*                    Medicine Shoppe International                              DEP                 
                                                                                                                                                                                                                                                                                                                                                                Meijer Acid Reducer 75 mg*b*                             Meijer Distribution Co                                     DEP                 
                                                                                                                                                                                                                                                                                                                                                                Publix Acid Reducer 75 mg*b*                             Publix Super Markets Inc.                                  DEP                 
                                                                                                                                                                                                                                                                                                                                                                Safeway Acid Reducer 150 mg*c*                           Safeway                                                    DEP                 
                                                                                                                                                                                                                                                                                                                                                                Safeway Acid Reducer 75 mg*b*                            Safeway                                                    DEP                 
                                                                                                                                                                                                                                                                                                                                                                Sunmark Acid Reducer 150 mg*c*                           McKesson                                                   DEP                 
                                                                                                                                                                                                                                                                                                                                                                Sunmark Acid Reducer 75 mg*b*                            McKesson                                                   DEP                 
                                                                                                                                                                                                                                                                                                                                                                TopCare Heartburn Relief 75 mg*b*                        Topco Associates LLC                                       DEP                 
                                                                                                                                                                                                                                                                                                                                                                TopCare Heartburn Relief 150*c*                          Topco Associates LLC                                       DEP                 
                                                                                                                                                                                                                                                                                                                                                                UP & UP Acid reducer 75 mg*b*                            Target                                                     DEP                 
                                                                                                                                                                                                                                                                                                                                                                Wal-Zan 75 Acid Reducer*b*                               Walgreens/Perrigo                                          DEP                 
                                                                                                                                                                                                                                                                                                                                                                Wal-Zan 150 Acid Reducer*c*                              Walgreens/Perrigo                                          DEP                 
                                                                                                                                                                                                                                                                                                                                                                Western Family Foods Acid Relief 75 mg*b*                Western Family Foods Inc.                                  DEP                 
  Abbreviations: NSAID, nonsteroidal anti-inflammatory drug; PPI, proton pump inhibitor. **a**Applies to all strengths and dosage forms unless otherwise noted. **b**ANDA 076760; manufacturer, Wockhardt, Mumbai, India. **c**ANDA 078653; manufacturer, Wockhardt, Mumbai, India. **d**ANDA 078884; manufacturer, Wockhardt, Mumbai, India.                                                                                                                                                           

###### 

Dietary supplements marketed in the United States and Canada listing *ortho*-phthalates as inactive ingredients in product labeling, 1995--2011.

  Generic name           Trade name   Manufacturer/distributor                             Phthalate   Supplement type                                                          
  ---------------------- ------------ ---------------------------------------------------- ----------- ------------------------------------------------------- -- ---------- -- -----------------
  Fish oil                            Omega 3+ Enteric Coated Fish Oil                                 Health Thru Nutrition/Epic4Health                          DEP, HMP      Nutritional
                                      Phyto-Therapy Omega 3 MLC Fish Oil, Enteric coated               Phytotherapy USA                                           DEP, HMP      
  Garlic                              Walgreens Finest Natural Garlic, tablets                         Walgreens                                                  DEP           Herbal
                                      Wholehealth GarlicHealth, Odorless Garlic                        Wholehealth                                                CAP, DEP      
                                      Nikken Garlic (Bio-Directed Nutri-Technology)                    Nikken                                                     CAP, DEP      
                                      Planetary Herbals GarliChol                                      Planetary Herbals                                          CAP, DEP      
                                      Top Care Garlic Tablet                                           Perrigo                                                    DEP           
                                      Ail Garlic (Canada)                                              Lyo-San Inc. (Lachute, Quebec, Canada)                     CAP, DEP      
  Magnesium                           Slow-Mag Magnesium Chloride with Calcium                         Purdue Products LP                                         DEP           Mineral
  Vitamin B                           Tri-Phos-B                                                       Montiff Inc.                                               CAP, DEP      Vitamin
  Vitamin C                           Viva Vitamin C 500 mg tablets (Canada)                           Viva Pharmaceutical Inc. (Canada)                          DEP           Vitamin
                                      Viva Vitamin C 1,000 mg tablets (Canada)                         Viva Pharmaceutical Inc. (Canada)                          DEP           
  Probiotics                          Advanced Naturals Ultimate FloraMAX (Canada)                     Renew Life Canada Inc.                                     CAP, DEP      Probiotic
                                      Acidophilus Complex with FOS (Canada)                            WN Pharmaceuticals Ltd. (Canada)                           CAP, DEP      
                                      Dophilus Select Plus (Canada)                                    Les Importations Biochala Inc. (Canada)                    CAP, DEP      
                                      Swiss Natural 5 Strain Dophilus Capsules (Canada)                Swiss Herbal Remedies Ltd./TheraPro (Canada)               CAP, DEP      
                                      Primadophilus Reuteri (Canada)                                   Nature's Way of Canada Ltd.                                CAP, DEP      
                                      Bifidus (Canada)                                                 Lyo-San Inc. (Canada)                                      CAP, DEP      
                                      Probioflor (Canada)                                              Lyo-San Inc. (Canada)                                      CAP, DEP      
                                      Lacto-B (Canada)                                                 Lyo-San Inc. (Canada)                                      CAP, DEP      
                                      Probiolomgum (Canada)                                            Lyo-San Inc. (Canada)                                      CAP, DEP      
                                      Protec (Canada)                                                  Natural Factors Nutritional Products Limited (Canada)      CAP, DEP      
  Enzymes                             Wobenzym N                                                       Mucos Pharma                                               DBP           Enzyme
  Misc combinations                   Venastat Leg Vein Health (until 2005)                            Pharmaton/Boehringer Ingelheim                             DBP           Natural product
                                      Bio ATP                                                          Bio Active Nutritional                                     CAP, DEP      Vitamin/Herbal
                                      Shenyang Hongyao Film Coated tablet (Canada)                     Wing Quon Enterprises Ltd.                                 DEP, HMP      Herbal
  Misc, miscellaneous.                                                                                                                                                          

*Canada.* Several RX and OTC medications approved for use in both the United States and Canada contained the same inactive ingredients in the product labeling (e.g., Asacol, Dulcolax) ([Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}); however there were some differences. Of particular note, the U.S. product labeling for Vivotif (Typhoid Vaccine Live Oral Ty21a) ([@r5]) did not detail the use of any phthalates, whereas the monograph for the Canadian product (Crucell Switzerland LTD 2010) specified use of "3--8 mg" of DBP and DEP and "27--33 mg" of HMP in the lacquer coating of each capsule. Several U.S. products were not available in Canada (e.g., Cardizem CD 360 mg, Dilt-CD), and some Canadian products were not distributed in the United States (e.g., Rhotral, Parsitan). In the LNHPD ([@r19]), 49 licensed supplement products were linked to phthalates as nonmedicinal ingredients, including 14 noted as containing DEP ([Table 3](#t3){ref-type="table"}).

*Changes over time.* A handful of products changed the use of specific excipients over time either by removing specific phthalates or adding phthalates to newly approved formulations. Solvay Pharmaceuticals removed DBP from its new FDA-approved formulations of pancrelipase capsules in April 2009. The older formulation, Creon Minimicrospheres, ([@r34]), which contained DBP and HMP, was replaced with Creon Delayed Release Capsules ([@r1]). New formulations for two strengths of OTC and RX ranitidine tablets from one manufacturer (Wockhardt USA LLC, Parsippany, NJ) that were approved in 2007, 2008, and 2009 (Wockhardt USA LLC 2007, 2008, 2009) used DEP as a film coating agent, whereas labels for \> 30 earlier approved ranitidine products did not list any phthalates.

In May 2010, Warner Chilcott modified the labeling for Asacol and Asacol HD under the sections "Precautions" and "Use in Specific Populations." The new labels provided cautions on use during pregnancy based on animal studies of DBP exposure and also added the estimated human daily intake of DBP from the maximum recommended daily dose of each product, "about 21 mg" and "about 48 mg" for Asacol and Asacol HD, respectively ([@r41], [@r42])

*Use in specific formulations.* Inclusion of phthalates---as well as the specific type of phthalate---in formulations for a particular drug was manufacturer specific, and on occasion dosage-form and strength specific. For example, the calcium channel blockers verapamil and diltiazem were available from 18 manufacturers in a number of strengths and time-release tablet and capsule formulations that contained different excipients. Although we found that DEP was included in two verapamil extended-release capsule products, both from one manufacturer ([@r25], [@r26]), other tablet and capsule formulations did not contain DEP. Among diltiazem products, only one of five strengths of Cardizem CD capsules ([@r6]) listed DEP, whereas manufacturers of other specific diltiazem capsule products utilized phthalates across all strengths: DBP in Dilt-CD ([@r3]), DEP in Diltiazem Extended-Release, Twice-A-Day ([@r24]), and HMP in Diltia XT ([@r43]).

*Other sources of information.* Detailed Internet searches led to the identification of two phthalate-containing products in patented release mechanisms, despite the fact that phthalates were not listed in the corresponding product labels. In a lawsuit brought against several manufacturers attempting to introduce new generic omeprazole products into the market in 2001, the manufacturer of Prilosec Delayed Release Capsules (AstraZeneca Pharmaceuticals LP, Wilmington, DE) argued that the new formulations infringed on certain sections of their patent involving the use of phthalates, including DEP and HMP, as coating agents ([@r4]). Communication with the manufacturer (AstraZeneca, personal communication) confirmed the use of HMP in the enteric coating layer of the pelletized drug found within the capsules. A similar patent infringement case ([@r32]) detailed the use of HMP in patents for carbamazepine extended release capsules (Carbatrol; Shire US Inc., Wayne, PA).

Discussion
==========

In this study, we identified a number of different phthalates as excipients in a variety of pharmaceutical products and dietary supplements sold in the United States and Canada. Although most of these products included phthalate polymers that are considered to be of low or no known toxicity, label information for several product formulations contained the phthalate diester DBP, which has been shown to cause adverse effects in experimental animal studies.

Although we attempted to review as many product listings as possible, this list cannot be considered comprehensive. Information on a number of products was unavailable due to product discontinuation and changes in manufacturers. Products may have changed their formulation over time, and the information available at the time of this review may not reflect the most recent version of the product formulation. In addition, some product information was incomplete (all inactive ingredients were not listed), which required that we seek information directly from the manufacturer. Although the FDA might have a more complete listing of products, including the type and amount of phthalate in specific drug products, this information is considered proprietary and cannot be accessed. Given the thousands of orally ingested products on the market (RX, OTC, and dietary supplements), it is difficult to quantify the prevalence of phthalate-containing products. However, it is informative to identify specific drug products that have included phthalates in their formulations.

It is also important to note the limitations and difficulties that were associated with some of the references used to compile the information for this study. Information on the specific excipients used in these products was generally available; however, it was not centrally located, comprehensive, or easily queried.

The FDA Approved Drug Products Database (Drugs\@FDA) did not contain labels for all products, especially generics, and only some entries contained copies of approval history documents that detail product formulations. Several additional labels were available on LabelDataPlus, DailyMed, or manufacturer web sites, demonstrating that electronic versions of the labels were available but were not linked to the FDA database. For example, detailed label information for prescription and OTC ranitidine tablets from Wockhardt was available on DailyMed and LabelDataPlus but not on Drugs\@FDA. The available OTC labels linked these approved products to labeling for several private label distributors (e.g., mass merchandise, grocery and drug store chains); however, these labelers and distributors often change the source for their private-label products over time. Neither Drugs\@FDA nor Health Canada's Drug Product Database permitted a systematic search of excipients in RX and OTC drug products. LabelDataPlus permitted queries for inactive ingredients; however, it was not comprehensive.

The *Physicians' Desk Reference* (Thomson Healthcare 1995--2010a) contained some additional product labels, especially older versions of labels and discontinued products (e.g., Theo-Dur; Key Pharmaceuticals Inc., Kenilworth, NJ); however, available information was limited to manufacturers who elected to include their products in the reference.

We found several NDAs and ANDAs containing information on excipients using Drugs\@FDA. However, because of the proprietary nature of the formulations, in most instances information concerning the type and amount of inactive ingredients used were redacted from the available documents. In LabelDataPlus, the strength of each inactive ingredient was provided for one omeprazole product---Omesec Delayed Release Capsules---listed as containing 0.144 mg DEP (Corporacion [@r8]); however, this was the only drug product for which we found this level of information to be available.

For a number of dietary supplement products, the available information on inactive ingredients was incomplete or unclear. Available label information sometimes described products as having an "enteric coating" without a specific listing of the components, making it impossible to determine whether any phthalates were present. Some fish oil capsules labels stated that they "may also contain" a variety of excipients, including HMP. Canada's LNHPD ([@r19]) and the NLM Dietary Supplements Labels Database permitted searches by inactive ingredients for licensed health products and supplements, but these databases are not comprehensive directories of marketed products.

In order to create a comprehensive listing of phthalate-containing products, individual manufacturers would have to provide information on their use of phthalates in specific product formulations. Such a list (similar to those available for other excipients such as gelatin or gluten) would not only facilitate critical research on the risks and safety of phthalate-containing medications but also would allow prescribers and consumers to select alternative products that are phthalate free. Estimates of exposure from these products can vary according to manufacturer-specific formulation characteristics, including the dosage form, dose, date of use, and country of manufacture. Researchers, consumers, and health care providers may need to contact manufacturers directly to confirm the presence of phthalates and the amounts used in a particular drug product.

Conclusion
==========

Using a combination of resources, we were able to identify \> 100 drug and dietary supplement products that indicated the use of *ortho-*phthalates as excipients, including labels of 50 RX, 40 OTC, and 26 dietary supplement product formulations that listed DEP and/or DBP (9 contained DBP, and 1 contained both DEP and DBP). The potential effects of human exposure to these phthalates through medications are unknown and warrant further investigation. The present findings should assist researchers in conducting the necessary studies of risk and safety of phthalates in human populations, but such efforts are limited by the lack of centralized, comprehensive, and publically available information on the presence of phthalates in the full range of RX, OTC, and dietary supplement products. Future research should pay particular attention to the amount of phthalate, specifically DBP, used in each dosage form so that estimates of exposure from medications and supplements can be quantified.

This work was supported by grant R01 HD059861 from the *Eunice Kennedy Shriver* National Institute of Child Health and Human Development, National Institutes of Health, and ES000002 from the National Institute of Environmental Health Sciences, National Institutes of Health.

K.E.K and A.A.M. are employed by and E.L.C. was previously associated with the Slone Epidemiology Center, which receives funding for unrelated research from various pharmaceutical companies. S.H.D. and A.A.M. have received unrestricted research and training grants from pharmaceutical companies, some of which manufacture drugs discussed in this article. The remaining author declares he has no actual or potential competing financial interests.
